Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine

Background: Anthracyclines such as doxorubicin remain a primary treatment for hematological malignancies and breast cancers. However, cardiotoxicity induced by anthracyclines, possibly leading to heart failure, severely limits their application. The pathological mechanisms of anthracycline-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheah, Irwin K., Tang, Richard M. Y., Wang, Xiaoyuan, Sachaphibulkij, Karishma, Chong, Suet Yen, Lim, Lina H. K., Wang, Jiong-Wei, Halliwell, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951880/
https://www.ncbi.nlm.nih.gov/pubmed/36829879
http://dx.doi.org/10.3390/antiox12020320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951880/
https://www.ncbi.nlm.nih.gov/pubmed/36829879
http://dx.doi.org/10.3390/antiox12020320

Ejemplares similares